Cost savings in quality improvement project to prevent venous thromboembolism

References 

1. Coalition to Prevent Deep Vein Thrombosis. www.PreventDVT.OrgAccessed March 26, 2007
2. Deep Vein Thrombosis: Advancing awareness to protect patient lives. White paper, page 3. Public Health Leadership Conference Washington, D.C., February 26, 2003. American Public Health Association.
3. White TJ. The use of pharmacoeconomics in formulary development: can this improve the way deep vein thrombosis is treated?. Am J Manag Care. 2001;7:S545–S550
   • MEDLINE
4. Leape L, Berwick D, Bates D. What practices will most improve patient safety?. JAMA. 2002;288:501–507
   • MEDLINE
   • CrossRef
5. Medicare Quality Improvement Community. SCIP process and outcome measures. http://quality indicators.ahrq.govAvailable at: Accessed March 19, 2007.
6. White TJ. The use of pharmoeconomics in formulary development: can this improve the way deep vein thrombosis is treated?. Am J Manag Care. 2001;7:S545–S550
   • MEDLINE
7. Maynard G, Halasyamani L. Venous thromboembolism prophylaxis for hospitalized patients: an implementation guide and model for improvement. Hospitalist. 2004;8:27–29
8. Clagett GP, Anderson FA, Levine MN, Salzman EW, Wheeler HB. Prevention of venous thromboembolism. Chest. 1992;102:S391–S407
9. Clagett GP, Anderson FA, Geerts W, et al. Prevention of venous thromboembolism. Chest. 1998;114:531S-60
10. Geerts WH, Heit JA, Clagett GP, et al. Prevention of venous thromboembolism. Chest. 2001;119:132S-75
11. Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolysis Therapy. Chest. 2004;126:338S-400
12. Caprini JA, Arcelus JI, Reyna JJ. Effective risk stratification of surgical and non surgical patients for venous thromboembolic disease. Semin Hematol. 2001;38:12–19
    • Abstract
    • Full-Text PDF (1187 KB)
    • CrossRef